Evidence map›Paper›PMID 30814730›Full record

ArticleNature2019

Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction.

Xindong Liu, Yun Wang, Huiping Lu, Jing Li, Xiaowei Yan, Minglu Xiao, Jing Hao, Andrei Alekseev, Hiep Khong, Tenghui Chen and 19 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 348 papers.

0numbers the graph read from it
0cells of the map it votes in
348citing papers in PubMed
19.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

348 citing papers in PubMed, 511 citations in OpenAlex.

  1. Trial
  2. Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Trial
  3. Article
  4. Article
  5. T-Cell Remodeling in Renal Fibrosis: From Acute Injury to Chronic Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Adoptive cell therapy in lung cancer: progress, challenges, and prospects.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  12. Metabolites · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  20. Review

288 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 8 institutions in 2 countries.

Xindong LiuInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. xindongliu@hotmail.com.
Yun WangInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Huiping LuTsinghua University, Beijing, China.
Jing LiTsinghua University, Beijing, China.
Xiaowei YanInstitute for Systems Biology, Seattle, WA, USA.
Minglu XiaoInstitute of Immunology, Third Military Medical University (Army Medical University), Chongqing, China.
Jing HaoTsinghua University, Beijing, China.
Andrei AlekseevMD Anderson Cancer Center, Houston, TX, USA.
Hiep KhongMD Anderson Cancer Center, Houston, TX, USA.
Tenghui ChenMD Anderson Cancer Center, Houston, TX, USA.
Rui HuangInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Jin WuInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Qiwen ZhaoInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Qi WuTsinghua University, Beijing, China.
Senlin XuInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Xiaohu WangTsinghua University, Beijing, China.
Wei JinTsinghua University, Beijing, China.
Shicang YuInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Yan WangInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Lai WeiZhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Aibo WangMD Anderson Cancer Center, Houston, TX, USA.
Bo ZhongMedical Research Institute, School of Medicine, Wuhan University, Wuhan, China.
Ling NiTsinghua University, Beijing, China.
Xiaolong LiuShanghai Institute of Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Roza NurievaMD Anderson Cancer Center, Houston, TX, USA.
Lilin YeInstitute of Immunology, Third Military Medical University (Army Medical University), Chongqing, China.
Qiang TianInstitute for Systems Biology, Seattle, WA, USA.
Xiu-Wu BianInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. bianxiuwu@263.net.
Chen DongTsinghua University, Beijing, China. chendong@tsinghua.edu.cn.
Tsinghua University · CNArmy Medical University · CNThe University of Texas MD Anderson Cancer Center · USSouthwest Hospital · CNChinese Academy of Sciences · CNInstitute for Systems Biology · USSun Yat-sen University · CNWuhan University · CN

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Role of Cul4A in Governing Th2-Type ToleranceR01HL143520 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI NURIEVA, ROZA INSAFETDINOVNA · 2018 to 2021
$1.6M
STAT1: New regulator of inflammatory Th17 and Th2 cellsR21AI120012 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI NURIEVA, ROZA INSAFETDINOVNA · 2016 to 2017
$440k
Role of Cul4A in Th2 tolerance and airway inflammationR56AI125269 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI NURIEVA, ROZA INSAFETDINOVNA · 2017 to 2017
$300k
Grail-targeting breaks the immune tolerance to melanomaR03CA219760 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI NURIEVA, ROZA INSAFETDINOVNA · 2017 to 2018
$160k
NCI NIH HHS P30 CA016672NCI NIH HHS R03 CA219760NHLBI NIH HHS R01 HL143520NIAID NIH HHS R21 AI120012NIAID NIH HHS R56 AI125269
6 · The paper itself

Abstract

T cells become dysfunctional when they encounter self antigens or are exposed to chronic infection or to the tumour microenvironment

Indexed as

GenomeAcetylationAnimalsArenaviridae InfectionsCell Line, TumorColitisEpigenesis, GeneticFemaleGene Expression RegulationHistonesImmune ToleranceImmunotherapyLymphocytic choriomeningitis virusMiceMice, Inbred C57BLNeoplasmsHistonesNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1Transcription Factor AP-1

Identifiers

PMID30814730
PMCPMC6507425
OpenAlexW2916738215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.